Learning from Sweden
The first large authoritative study to take
this perspective was Swedish.(2) This study, published in 1997,
illustrates the sort of research that is feasible only in Sweden.
The authors had at their disposal the birth records of all deliveries
at five different hospitals from 1874 through 1961 (there is
no other country where such data is available). They also had
access to the National Cancer Registry and the Uppsala Regional
Cancer Registry from 1958 through 1994 (this, too, cannot be
done outside Sweden). Thus, they could collect data from birth
records regarding 1068 women who developed breast cancer and
2727 controls individually matched for date of birth.
The authors found a markedly and significantly reduced risk
in women whose mothers had ‘toxemia’ (pre-eclampsia
or eclampsia): the odds ratio was 0.41. They found a significant
excess risk (odds ratio 2.16) in women who had neonatal jaundice
or who were born before 33 weeks (odds ratio 3.96). There was
also an increased risk in non-identical twins, but the excess
was at the limit of statistical significance. There was no evidence
in these data of a statistically significant or even substantial
association of breast cancer risk with birth size indicators
(weight and length at birth and placental weight). Because pregnancy
toxaemia is associated with low levels of oestrogens, while
neonatal jaundice, severe prematurity, and dizygotic twins are
associated with high levels, the authors could suggest that
oestrogens play a critical role during the intrauterine period.
As early as 1992, the same team of Uppsala University Hospital
had published a smaller study using the same method, of 458
breast cancer cases and 1197 matched controls.(3) Pre-eclampsia/eclampsia
when the mother gave birth to her daughter was already associated
with a highly-significant reduction in the risk of breast cancer.
The trends for increased breast cancer incidence with increasing
birth weight, birth length, and placental weight were not statistically
significant.
More recently, the same Swedish team conducted two studies
to clarify the risk of breast cancer in prematurely-born women.
According to a first study the risk in women born before 31
weeks’ gestation was significantly increased(4), but a
further enlarged study could not confirm the statistical significance
of the previous resuts.(5)
Not only did the Uppsala epidemiology team explore pre- and
perinatal risk factors, they also conducted studies and suggested
interpretations that could reinforce the plausibility of the
correlations they had brought to light. Data regarding all 115,670
women born between 1858 and 1958 that was reported to the Swedish
Cancer Registry in 1958-89 as having breast cancer, identified
a significant seasonal pattern for women born between 1880 and
1920: women born in June had a 5% higher risk of breast cancer
than those born in December.(6) In contrast, there was no evidence
of birth seasonality among 440,948 women with cancer at other
sites.
One can conclude that pre- and peri-natal factors influence
breast carcinogenesis, since exposures relevant to breast cancer
risk later in life are unlikely to be related to month of birth.
On the other hand birth outcomes and particularly pre-eclampsia,
are influenced by the season of birth. In Scandinavian countries
giving birth in winter is a risk factor for pre-eclampsia.
One may also wonder if pre-eclampsia exposure could be an
indirect causal factor, by affecting, for example, pubertal
development and adult morphology. Uppsala researchers offered
answers to this question by interviewing 230 women with verified
pre-eclampsia exposure during fetal life and 359 non-exposed
women.(7) While babies of women who had pre-eclampsia were lighter
and shorter for gestational age, in young adulthood there were
no differences in height, body mass index, waist-to-hip ratio,
or age at menarche. The variance in final height was to a great
extent explained by parental height. These data indicate that
neither adult anthropometry nor age at menarche is significant
in the causal pathway between intra-uterine pre-eclampsia exposure
and the reduced risk of breast cancer.
Such conclusions are reinforced by the results of another
study by the same team of researchers. They retrieved mammograms
for 370 women aged 40 to 74 years old with no history of breast
cancer, for whom birth weight, birth length, placental weight
and other birth characteristics were indicated in their birth
records at the Uppsala University hospital.(8) Blind evaluation
of the mammographic parenchymal patterns allowed the subjects
to be classified as high- risk versus low-risk. The high-risk
pattern was significantly associated with a high weight of the
placenta, i.e. the main oestrogen-producing organ during pregnancy.
These results are compatible with hypotheses suggesting that
pregnancy oestrogens influence the risks of breast cancer in
the offspring.
A more recent American study found that birth weight was positively
associated with mammographic breast density among postmenopausal
women and more weakly among premenopausal women.(9) In this
study the prenatal and perinatal risk factor data were ascertained
by mailed questionnaires only.
The unrivalled data available at Uppsala Hospital have also
been analysed by British epidemiologists.(10) First, they investigated
whether size at birth and rate of fetal growth influence the
risk of breast cancer in adulthood in 5358 women born during
1915-1929, alive and traced with the 1960 census. They could
conclude that size at birth, particularly length and head circumference,
is associated with risk of breast cancer in premenopausal women.
Fetal growth rate, as measured by birth size adjusted for gestational
age, rather than size at birth, may be the aetiologically-relevant
factor in premenopausal breast cancer. Then, they enlarged the
study by looking at 11,166 women born during 1915-1929 and investigated
the incidence of all sorts of cancer in relation to birth characteristics.(11)
They found that women who had higher birth weights had increased
rates of breast cancer under age 50 years, but reduced rates
of endometrial (corpus uteri) cancer at all ages. There was
no evidence of associations with other cancer sites.
Outside Sweden
The same researchers completed their enquiries among a British
population in order to interpret the association between birth
weight with premenopausal breast cancer.(12) They examined data
from 2176 women born in 1946 for whom there were prospective
measurements of birth weight and body size throughout life.
During follow-up, 59 breast cancer cases occurred (21 premenopausal).
The authors concluded that the association of birth weight with
premenopausal breast cancer risk was not mediated through childhood
growth.
It is notable that, outside Sweden, birth weight has usually
been the only proxy measurement available to evaluate the effects
of prenatal environmental factors. This is the case with a large
Danish study investigating a cohort of 106,504 women.(13) A
total of 2,334 cases of primary breast cancer was diagnosed
among women with birth weight between 500-6000g. Of these, 40%
was diagnosed with primary breast cancer at the age of 50 years
or older. A significant association between birth weight and
breast cancer was found, equivalent to a 9% increase in risk
per 1,000g increase in birth weight. This statistic was observed
for all age groups, representing both pre- and postmenopausal
women, and irrespective of tumour characteristics. Adjustment
for age at first birth and parity did not influence the results.
When birth weight is the only criterion available to evaluate
early risk factors, the results provided by different epidemiological
teams can be ambiguous. The history of studies exploring correlations
between birth weight and risks of breast cancer started in Honolulu,
with a paper published as early as 1988.(14) Comparing 153 cases
and 461 controls, the authors found that cases had a smaller
mean birth weight (3120g) than controls (3162g).
Another study in the USA found that the association between
birth weight and breast cancer in women aged 21-45 years followed
a ‘J’-shaped curve, with an odds ratio of 1.3 for
women whose birth weight was less than 2,500g, and an odds ratio
of 1.7 for women whose birth weight was 4000g or more.(15) Surprisingly,
women aged 50-64 years who weighed 4,000g or more at birth appeared
to be at slightly-reduced risk of breast cancer. The authors
of a similar study, looking at women aged 14-37 years, also
found a J-shaped association between birth weight and breast
cancer risk;(16) very high birth weight (more than 4,500g) was
associated with the greatest elevation.
Another American study could not reach statistical significance
regarding the correlations between birth weight and the risks
of breast cancer.(17) We must also mention the Shanghai Breast
Cancer Study in 1996-98, involving 288 cases and 350 controls:
after adjustment for confounding factors, women who were 4000g
or more at birth were not at increased risk of premenopausal
breast cancer relative to women whose birth weight was 2500-2999g.(18)
Complementary Data
We stress the importance of data that indirectly identify
the prenatal period as a critical period for genes-environment
interaction, where the risk of breast cancer is concerned.
It is worth interpreting an investigation of cerebral asymmetry
among 79 women with breast cancer and 97 controls.(19) Women
with breast cancer had a reversed pattern of cerebral asymmetry
significantly more often than did controls for both frontal
and occipital widths. We have previously compiled a great diversity
of data suggesting that handedness, and therefore brain asymmetry,
is also to a great extent determined during fetal life.(20)
Among such data we have mentioned studies of handedness in relation
to maternal emotional states in pregnancy, studies of laterality
among women exposed prenatally to Diethylstilbestrol (DES)(21)
and to ultrasound, and studies relating laterality and birth
complications.
It is significant that prenatal exposure to DES is a factor
influencing both the process of laterality and the risk of breast
cancer. A preliminary American study, looking at a cohort of
4821 exposed women and 2095 unexposed women, followed for an
average of 19 years, found an overall 40% excess risk; however
the differences were not statistically significant.(22) After
a longer follow-up it appeared that the excess risk was statistically
significant after age 40 years.(23)
Recently, the possible genetic effects of DES on human breast
tissue have been examined. Prenatal DES exposure does not significantly
increase genomic instability in breast epithelium.(24) This
leads us to the conclusion that the consequences of prenatal
DES exposure are probably mediated by the proliferative effects
of oestrogens, rather than by ‘somatic mutations’.
‘Somatic mutations’ are acquired during a person’s
lifetime and are present only in certain cells; they are not
inherited.
Learning From Negative Findings
To this accumulation of data that led us to include the genesis
of breast cancer in the framework of ‘womb ecology’,
we must add the negative findings of two large studies regarding
exposure to breast milk in infancy.
The authors of the two “nurses’ health studies”
(Harvard Medical School) did not observe any association between
having been breastfed and the development of breast cancer later
in life among premenopausal women or postmenopausal women.(25)
No significant trend was observed with increasing duration of
breastfeeding. The conclusions of another large American study
were similar;(26) interestingly it appeared that breast cancer
risk was not increased by having been breastfed by a mother
who later developed breast cancer, compared to having been breastfed
by a mother who never developed breast cancer. Two previous
smaller studies had suggested that exposure to breast milk might
reduce the risks of breast cancer, but the results were at the
limits of statistical significance.(27,28) Such negative findings
regarding postnatal life are important to confirm the limits
of the period that is critical in the pathogenesis of breast
cancer.
There are two reasons why we focused on female breast cancer.
First, the prevalence of male breast cancer is less than 1%
of total cases. Also, we could find only one study of male breast
cancer from a primal health research perspective. Primal Health
Research is still a new branch of epidemiology.
The Future
We have reached an historical phase when the pathogenesis
of breast cancer has become a chapter of “womb ecology”.
The way is open for a new subgroup of studies. Today, we all
have in our adipose tissue hundreds of synthetic fat-soluble
chemicals that did not exist some decades ago. We understand
that many of them behave like endocrine disruptors, and more
precisely mimic oestrogen.
We need studies exploring the long-term consequences of prenatal
pollution. Until now we must rely on a small number of animal
experiments. For example, according to a recent study, intrauterine
exposure of rats to bisphenol A at 2.5 parts per billion can
induce breast cancers detectable at age 50 and 95 days.(29)
It is increasingly obvious that causes of endocrine-related
cancers or susceptibility to cancer are more likely to be a
result of developmental exposures rather than exposures existing
at, or near the time, of tumour detection.
Michel Odent
References:
1 – Odent M. Primal Health. Century Hutchinson. London
1986
2 - Ekbom A, Hsieh CC, Lipworth L, et al. Intrauterine environment
and breast cancer risk in women: a population-based study. J
Natl Cancer Inst 1997 Jan 1;89(1):71-6
3 - Ekbom A, Trichopoulos D, Adami HO, et al. Evidence of prenatal
influences on breast cancer risk. Lancet 1992 Oct 24;340(8826):1015-8
4 - Ekbom A, Erlandsson G, Hsieh C, et al. Risk of breast cancer
in prematurely born women. J Natl Cancer Inst 2000 May 17;92(10):840-1
5 - Kaijser M, Akre O, Cnattingius S, Ekbom A Preterm birth,
birth weight, and subsequent risk of female breast cancer. Br
J Cancer 2003 Nov 3;89(9):1664-6
6 - Yuen J, Ekbom A, Trichopoulos D, et al. Season of birth
and breast cancer risk in Sweden. Br J Cancer 1994 Sep;70(3):564-8
7 - Ros HS, Lichtenstein P, Ekbom A, Cnattingius S. Tall or
short? Twenty years after preeclampsia exposure in utero: comparisons
of final height, body mass index, waist-to-hip ratio, and age
at menarche among women, exposed and unexposed to preeclampsia
during fetal life. Pediatr Res2001 Jun;49(6):763-9
8 - Ekbom A, Thurfjell E, Hsieh CC, et al. Perinatal characteristics
and adult mammographic patterns. Int J Cancer 1995 Apr 10;61(2):177-80
9 - Cerhan JR, Sellers TA, Janney CA, et al. Prenatal and perinatal
correlates of adult mammographic breast density. Cancer Epidemiol
Biomarkers Prev 2005 Jun;14(6):1502-8
10 - McCormack VA, dos Santos Silva I, De Stavola BL, et al.
Fetal growth and subsequent risk of breast cancer: results from
long term follow up of Swedish cohort. BMJ 2003 Feb 1;326(7383):248
11 - McCormack VA, dos Santos Silva I, Koupil I, et al. Birth
characteristics and adult cancer incidence: Swedish cohort of
over 11,000 men and women. Int J Cancer 2005 Jul 1;115(4):611-7
12 - dos Santos Silva I, De Stavola BL, Hardy RJ, et al. Is
the association of birth weight with premenopausal breast cancer
risk mediated through childhood growth? Br J Cancer 2004 Aug
2;91(3):519-24
13 - Ahlgren M, Sorensen T, Wohlfahrt J, et al. Birth weight
and risk of breast cancer in a cohort of 106,504 women. Int
J Cancer 2003 Dec 20;107(6):997-1000
14 - Le Marchand L, Kolonel LN, Myers BC, Mi MP. Birth characteristics
of premenopausal women with breast cancer. Br J Cancer 1988
Apr;57(4):437-9
15 - Sanderson M, Williams MA, Malone KE, et al. Perinatal factors
and risk of breast cancer. Epidemiology 1996 Jan;7(1):34-7
16 - Innes K, Byers T, Schymura M Birth characteristics and
subsequent risk for breast cancer in very young women. Am J
Epidemiol 2000 Dec 15;152(12):1121-8
17 - Hodgson ME, Newman B, Millikan RC Birthweight, parental
age, birth order and breast cancer risk in African-American
and white women: a population-based case-control study. Breast
Cancer Res 2004;6(6):R656-67. Epub 2004 Sep
18 - Sanderson M, Shu XO, Jin F, et al. Weight at birth and
adolescence and premenopausal breast cancer risk in a low-risk
population. Br J Cancer 2002 Jan 7;86(1):84-8
19 – Sandson TA, Wen PY, Lemay M. Reversed cerebral asymmetry
in women with breast cancer. Lancet 1992; 239:523-24
20 – Odent M. Where does handedness come from? Primal
Health Research Newsletter. Summer 1998. Vol6 no1
21 – Scheirs JG, Vingerhoets AJ. Handedness and other
laterality indices in women prenatally exposed to DES. Journal
of clinical and experimental neuropsychology 1995;17(5):725-30
22 – Palmer JR, Hatch EE, Rosenberg CL, et al. Risk of
breast cancer in women exposed to diethylstilbestrol in utero:
prelimiinary results (United States). Cancer Causes Control
2002 Oct;13(8):753-8
23 – Palmer JR, Wise LA, Hatch EE, et al. Prenatal diethylstilbestrol
exposure and risk of breast cancer. Cancer Epidemiol Biomarkers
Prev 2006 Aug;15(8):1509-14
24 - Larson PS, Ungarelli RA , de Las Morenas A, et al. In utero
exposure to diethylstilbestrol (DES) does not increase genomic
instability in normal or neoplastic breast epithelium. Cancer
2006 Nov 1;107(9):2122-6
25 - Michels KB, Trichopoulos D, Rosner BA, et al. Being breastfed
in infancy and breast cancer incidence in adult life: results
from the two nurses' health studies. Am J Epidemiol 2001 Feb
1;153(3):275-83
26 - Titus-Ernstoff L, Egan KM, Newcomb PA, et al. Exposure
to breast milk in infancy and adult breast cancer risk. J Natl
Cancer Inst 1998 Jun 17;90(12):921-4
27 – Freudenheim JL, Marshall JR, Graham S, et al. Exposure
to breastmilk in infancy and the risk of breast cancer. Epidemiology
1994;5(3):324-31
28 – Weiss HA, Potischman NA, Brinton LA, et al. Prenatal
and perinatal risk factors for breast cancer in young women.
Epidemiology 1997;8(2):181-7
29 - Murray TJ, Maffini MV, Ucci AA, et al. Induction of mammary
gland ductal hyperplasias and carcinoma in situ following fetal
bisphenol A exposure. Reprod Toxicol 2006 Oct 24; [Epub ahead
of print]
(Click here to go back to the top of the page)